Dollars at work


A personal message from Sarah Roth, President & CEO of BC Cancer Foundation…

Dear Riders,

Thank you for your support of The Ride to Conquer Cancer® presented by Wheaton Precious Metals® benefiting BC Cancer Foundation. Your tireless dedication to this event has translated into more than $77 million raised in eight years.

We know from past experience that kicking off your fundraising earlier means a much greater chance of success for you and your fellow Riders. It also means that the money can be put to use earlier.

With this in mind, we are adapting our jersey program for The 2017 Ride. We are asking that each Rider raise $1,000 by Sunday, February 5, 2017 to receive a complimentary Ride jersey.

By reaching the $1,000 mark by February 5, you’ll secure your Ride jersey while helping to fund pressing needs, such as:

  • The expansion of clinical trial programs across the province so more patients have access to a clinical trial when standard therapy options may have run out.
  • The expansion of PET/CT capacity at the BC Cancer Agency. The BC Cancer Foundation is actively raising funds for a much needed PET/CT scanner for the 77,000 British Columbians living with cancer, which will increase accessibility to state-of-the-art care.
Sarah Roth

We dare to believe in a world free from cancer and are doing everything we can to get there faster. Thank you again for your extraordinary support of cancer research and care.

Kind Regards,

Sarah Roth
President & CEO, BC Cancer Foundation


Bringing together communities of cancer survivors, cyclists and supporters, The Ride to Conquer Cancer has raised more than $77 million in eight years, making it B.C.’s largest cycling fundraiser. Funds raised ensure researchers and clinicians at the BC Cancer Agency have the support needed to re-invent the standard of cancer care through leading-edge research.

The Ride to Conquer Cancer series is Canada’s largest peer-to-peer fundraising event.

The BC Cancer Foundation is the largest funder of cancer research in the province and is on a mission to reduce the incidence of cancer, reduce the mortality rate of people with cancer and improve the quality of life of people living with cancer.


Funds from the Ride have:

  • Supported more than 47 projects, investigating more than 50 different cancer types
  • Enabled more than 300 patients to be submitted to POG
    First-of-its-kind, the Personalized Onco-Genomics Program allows world-leading scientists and doctors to map the genomic structure enrolled patient’s cancer to help determine potential drug targets and treatment based on a biological rationale. Funds raised through The Ride are enabling the BC Cancer Agency to continue enrolling patients into this ground-breaking clinical study.
  • Supported the construction of the Conconi Immunotherapy Lab
    Funds continue to support incredible progress for the BC Cancer Agency's Immunotherapy research program, as well as the newly constructed Conconi Lab within the Deeley research Centre at the Vancouver Island Cancer Centre, in Victoria, establishing the provincial hub of immunotherapy treatment and development. Support will help make T cell therapy a reality for cancer patients in B.C., bringing a critical new treatment solution to the clinic.
  • Supported the development of Canadian-first “OncoPanel” with more than 2,000 BC cancer patients eligible annually
    A new multi-gene analysis panel is now available to oncologists across B.C. as a provincial diagnostic tool, meaning a more personalized approach to treatment for thousands of eligible cancer patients. This is the first gene panel to be available province-wide and as part of standard cancer care in Canada for acquired cancers.
  • Enhanced brain cancer care
    Brain cancer care in B.C. has been transformed, enabling patients to be seen by neuro-oncology specialists quickly and effectively, in one visit and at one site.
  • Supported a new drug for advanced prostate cancer to enter clinical trials
    Funds will further support a new prostate cancer drug developed at BC Cancer Agency called EPI-506 that is currently in clinical trial. This new treatment option offers hope for the thousands impacted by prostate cancer in B.C. and around the world.
  • Purchased a second state-of-the-art PET/CT scanner & reduced wait times
    -- Funds raised through The Ride supported the purchase of the BC Cancer Agency’s second PET/CT scanner and allowed for an upgrade to an existing scanner. As a result, wait times have been reduced and the number of patients able to receive these life-saving scans have doubled.